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14.1
The skull - origin and target of distant metastases
A. Dunsche', H. Terheyden2, A. Eckardt2, 'Dept. of Oral and
Maxillofacial Surgery, University of Kiel, 2Dept. of Oral and
Maxillofacial Surgery, Hannover Medical School, Germany
Among all malignant tumors of the jaws, osteosarcomas are the most
common primaries to distant metastases. In this location the prognosis is
better compared to other parts ofthe skeleton, because 90% are grade I or 2.
Therefore surgery is the treatment of choice. 20% develop distant
metastases, mainly in the lung or the skeleton. Reconstructive surgery could
provide a better prognosis and quality oflife after agressive surgery.
Only 40 cases ofprimary intraosseous carcinoma (PIOC) of the jaws have
been reported in literature. Treatment and prognosis do not differ from other
carcinomas involving the mandible. 75% show lymphnode metastases. A 53-
year-old patient with a PIOC presented in our department with a
pathological fracture of the mandible. One year after surgery and
radiotherapy he died from a local recurrence.
1% of skeletal metastases involve the skull and metastatic tumors represent
1% of malignancies in the maxillofacial region. In the last 15 years 39
patients presented with metastases in the skull from distant primaries. 22
were located in the mandible, 13 in the maxilla and 2 in the orbital region.
Most common primary sites were the breast, lung, prostate and uterus. Four
patients showed melanoma metastases. In three cases the origin remains
unknown. Hypaesthesia, swelling and pain were the most commonly
reported symptoms. The distant metastases were diagnosed two months to
ten years after the diagnosis ofthe primary. The palliative treatment includes
radio-, chemo-, immunotherapy and surgery. To prevent exulceration or
fractures of the mandible, a complete resection of the metastasis can be
useful. In fourteen cases supportive therapy was the only treatment. Most of
the patients died within one year after diagnosis. Treatment modalities have
to be selected to improve the patients' quality of life and have to consider
interdisciplinary cooperation.
14.3
Surgical treatment of bone metastases
H.-W. Ulrich, J. Hassenpflug, Dept. of Orthopedic Surgery,
University ofKiel, Germany
Bone metastases are the most frequent malignant osseous lesions.
Their operative treatment is increasingly important while the
survival rates ofthe patients are improving. The aim oftreatment is
perservation of mobility, reduction of pain and improvement of
quality of life. An interdisciplinary approach with combined
operative treatment, chemotherapy and radiationtherapy is
essential for success.
Combined osteosynthesis with replacement ofthe defect by bone-
cement is the standard procedure. If there are metastases in or
close to joint structures special tumor-endoprotheses may restore
fimction and stability of the limbs. Amputation is very seldomly
recommended.
Indication for operative treatment ofmetastasis ofthe spine has to
consider pending or manifest neurological deficits, stability and the
prospective survival time and weigh the results of operative and
non-operative therapy thoroughly. The results of anterior
approaches are more favorable than isolated dorsal stabilisation.
But theyhave a higher risk and potential for failiure. The prognosis
of metastasis in the pelvis is often bad, surgical treatment is
seldomly recommended, exept total hip replacement. Overall the
indication for surgical treatment ofbone metastases should not be
done according to the question oftechnical feasability, but in order
to improve the general situation ofthe patient.
14.2
Bone metastases in head and neck cancer
J. Buntzel, K. Kuttner, M. Glatzel, Dept. ofORL, Plastic Surgery,
Clinic ofSuhl,Germany
Objective: Metastatic bone disease is a rare complication in head neck
cancer. Thepresented retrospective analysis demonstrates the difficulties
ofdiagnosis and treatment in thispatient-subgroup.
Material and methods: We analyzed the follow-up-data of 515 patients
with head neck cancer in the years between 1992 and 1997. All patients
had an advanced squamous cell carcinoma ofthe head neck region (stage
Imor IV ofUICC).
Results: 25 out of 515 patients developed metastatic bone disease
(incidence 4,8%). The median time of occurrence was 23 months after
primary treatment (range 13 to 46 months). The bone metastasis was a
single-organ-metastasis only in 13 out of 25 patients (52%). Initial signs
ofmetastatic disease werepain(21/25), pathological fractures (2/25) and
sensoneuronal disturbances (2/25). The diagnosis was a screening-result
in 8/25patients.Diagnostic steps were the bone-scintigraphy and X-ray-
investigations ofthe regions ofinterest. Bone metastasis was localized in
the vertebral column (15/25), pelvic bones (7/25), andextremities (3/25).
The treatment differed according to the stage ofthe disease: In 3 patients
we combined a clodronate-ionfusion with a polychemotherapy
(generalized metastasis). 7 patients got clodronate alone. Surgical
stabilization was favoured in 4 patients combined with palliative
radiotherapy. 8 patients wished a symptomatic therapy of pain and
further 3 patients were irradiated combined with clodronate-infusions.
The median survival time was 7 months (range 2 to 19 months).
Condusion: The metastatic bone disease is also an important kind of
distant metastasis in head neck cancer patients. Usually it occurs in an
advanced stage of the tumor-disease. Besides the treatment of pain the
individual therapy plans should include clodronate therapy, irradiation
and surgical stabilization.
14.4
Metastases affecting the central nervous system - neurosurgical
aspects
H.M. Mehdom, B. Schrader, S. Langer, A. Nabavi, T. Eichmann, Dept.
ofNeurosurgery, University ofKiel, Germany
Surgical treatment of metastases to the brain, its surrounding
structures and the spinal column has repeatedly been discussed in
recent years withregard to indications and results.
In the series ofpatients operated upon between April 1991 and
1997, the indications foroperations were asfollows:
- Acute or progressive neurological deficit leading to
neuroradiologicaldiagnostics andpresentation of an intracranial or
intraspinallesion'without knownprimary tumor
- Acute or progressive neurological deficit leading to
neuroradiological diagnostics in the presence of a known primary
tumorwith demonstration of
- a metastasis
- a second tumor e.g. primary intracranial orintraspinal tumor
Indication for surgery in the presence of a known primary tumor
depends mainly on the total tumor volume carried by the patient.
In cases ofsolitary metastasis we advocate surgery in almost all
cases. Inmultiple metastasis the indication has to be individualized.
Modem microneurosurgical techniques and computer assisted
surgery for intracranial lesions and instrumented spinal stabilization
have significantly reduced the surgical morbidity and duration of
hospitalization for this multimorbidpatientpopulation.
The more aggressive approach to metastatic disease ofthe central
nervous system is warranted by the decreased surgical risk and
improved neurological outcome.Distant metastases 43
14.5
Metastatic tumors ofthe orbit
R. Rochels, S. Behrendt, Department ofOphthalmology,
University ofKiel, Germany
Metastatic tumors of the orbit are not uncommon. The most
frequent symptom is proptosis, with the exception ofmetastases of
breast tumors where scarring can lead to enophthalmos and the
sign of the ,,frozen globe". Other symptoms encomprise pain,
inflammation and functional defects such as deterioration ofvision
or ocular motility disorders.
The orbital metastasis is the first manifestation of an unknown
primary tumor in up to 50% of these patients. Therefore, every
effort has to be made to obtain a definite diagnosis on every orbital
mass ofunknown origin. CT-scan and MRI are very helpful tools.
Although most orbital metastases are poorly differentiated and
often lack resemblance with the primary tumor, surgical biopsy and
histologic examination of the tissue remain a mainstay in
diagnostics ofthese lesions. We therefore believe that experience
in orbital surgery is advantageous when dealing with this kind of
diseases.
Tumors commonly leading to orbital metastases are neuroblastoma
and Ewing's sarcoma in children and carcinomas of the breast,
lung, prostate, the gastrointestinal tract and the kidneys in adults.
However, almost every other neoplasm can occasionally lead to a
metastatic tumor ofthe orbit.
The prognosis depends on the underlying process and is relatively
poor in the majority oforbital metastases. However early diagnosis
can lead to a specific therapy for some of these patients and
improve life-quality for most ofthem.
14.7
Pulmonary metastases from head and neck primaries
P. Dohrmann, Dept. ofSurgery and Thorax Surgery, University of
Kiel, Germany
With improved control of cancer from head and neck, distant
metastases are frequently more seen and are becoming a more
common cause ofmorbidity and mortality. With the exception of
primary tumor of the lip, tonsil and adenoid, lung is the most
common distant metastases site and usually occur within 2 years of
the initial diagnosis.
Literature about a complete cohort of head and neck cancer
patients who developed pulmonary metastases is rare.
When the lungs are the only site of distant metastases, surgical
resection should be considered. Isolated pulmonary metastases are
potentially curable by surgical resection.
Preconditions for pulmonary resection are locoregional control of
the primary lesion, no demonstrable extrapulmonary sites of
disease, good surgical risk and no other effective therapy available.
CT scanning ofthe lung has proven to be the best diagnostic test
for following the progress of metastatic lung lesions. A 3 mm
nodule can be detected by this scan. Care must be taken, however,
because onlyhalfthe lesions ofthis size are malignant.
Pulmonary metastasectomy could be performed through
thoracotomy, thoracoscopy or through median stemotomy in
patients with bilateral metastases.
Five year survival rates of up to 43% have been reported with
metastasectomy.
The value of resection in patients with more than one malignant
pulmonary nodule remains to be defined forthis group ofpatients.
14.6
Metastases from and to the eye
B. Wiechens, S. Behrendt, Dept. ofOphthalmology, University of
KieL Germany
Metastases derived from primary ocular tumors are usually rare
with the exception of choroidal/ciliary body melanomas and
retinoblastomas. Most common metastatic sites are liver, lung and
bones. However, almost every other site is possible.
Due to longer survival ofpatients and improved clinical detection
nowadays metastatic cancer to intraocular structures, mainly the
choroid, is believed to be the most common form of intraocular
malignancy. Tumors commonly leading to intraocular metastases in
adults are carcinomas ofthe breast, lungs and gastrointestinal tract,
although a variety of other cancers can metastasize to ocular
structures such as carcinomas of the genitourinary tract and
lymphoid tumors. In children Ewings's sarcoma, neuroblastoma
and congenital fibrosarcoma have been reported to cause
metastastic eye disease.
The most frequent initial symptoms are visual disturbances and
inflammatory reactions. Usually ocular metatases, in up to 30%
multifocal, occure unilaterally. In 30%, however, both eyes are
involved.
The therapeutic approach to ocular tumors, primary or metastatic,
depends on the degree of activity and symptoms and consists in
irradiation, surgery, chemotherapy or observation. Whereas the
prognosis for life of primary ocular tumors is good (except
retinoblastoma) mean survival time in patients with metastases to
intraocular structures is generally poor, ranging from 3 to 8
months, in patients with breast cancer of up to 18 month after
ocular diagnosis.
14.8
Resection of lung neoplasic noduls long term benefit survvial
from head and neck cancer patients
C. Domenge, M. Batouche, J. Bellamy, P. Dartevelle, F. Janot, P.
Marandas, B. Luboinski, Inst. Gustave-Roussy, Villejuif, France
Pulmonary metastasis fromhead andneck cancer aregenerallytreatedby
chemotherapy alone; theyhavegenerally a poorprognosis.
In this retrospecitve study, we describe a selected population ofpatients
treatedby surgery on lungneoplasic noduls. 159 patients with pulmonary
metastasis of squamous cell carcinoma from head and neck were treated
between 1988 and 1994. All patients have been primary site treated and
controlled and had a negativework up for other metastasic sites. Patients
characteristics: 150 men, 9 women - median age: 55.2, PS = 0.1.
Oropharynx 66 (41.50%); oral cavity 34 (21.4%); larynx 24 (15.1%);
hypopharynx: 17 (10.7%); maxillary sinus 9 (5%); cervical metastasis
adenopathy 5 (3.1%). All patients werefree ofclinical symptoms, except
3, and lung opacity was detected by routine chest X-ray. Bronchoscopy
was performed on 157/159; it was negative for 147 and positive for 11.
All patients were treated with curative intent, the types of surgery were:
lobectomy (59%), tumorectomy (21%), pneumonectomy (15%),
bilobectomy (4%). The median interval between primary tumor and the
diagnostic ofthe'lungnoduls was 32 months. Halfpatients are alive at 34
months and 33.3% at five years. 12 patients (13%) died from unknown
cause and 33 patients (35.9%) died from intercurrent disease; 36 (39%)
ofpatients died ofother metastasis evolution and other site (bone, brain,
cutaneous, liver); only one (1%) with local relapse. Two prognostic
factors were identified in this study: mediastinal lymph node involvement
and positive surgical margin on specimen. There is no correlation in
disease free interval when metastasis occure in less than one year on
morethan one year afterprimary.
In conclusion: Surgery of neoplasic lung noduls is a good treatment
since it enables survival in selectedpatients population.44 Distant metastases
14.9
The value of chemotherapy and interventional treatment
modalities ofliver metastases
C. Stoffregen, T. Arendt, U.R. Folsch, Dept. of. Internal Medicine,
University ofKiel, Germany
With improved local control of tumor growth distant metastases
are becoming a more common cause ofmorbidity and mortality in
head and neck cancer. This trend indicates a longer period of
survival allowing distant metastases to grow. Lung, bones and liver
are the major sites ofmetastatic diseases. Isolated metastases are
seen in 2 to 7 per cent only in those patients. Therefore special
strategies for localregional treatment ofliver metastases have to be
considered only in rare cases. On the other hand a short median
survival time ofabout 3 months ispredicted with the appearance of
liver metastases. Therefore the decision about management has to
be placed in an interdisciplinary concept to optimize combined
systemic therapy with taxanes for example and locoregional
treatment modalities. Different palliative approaches are at
disposal: transarterial chemotherapy, chemoembolisation or the
sonographic guided repeated percutaneous alcohol injections. The
decision, which therapy is suitable, depends on the prognosis ofthe
individual patient. Alcohol injection is the aproach with low side
effects. Chemoembolisation is the method for larger metastases,
which do not respond to alcohol injection. In cases of multiple
metastases in both liver lobes, principally a chemoperfusion is
possible. However it should only be realised in metastatic disease
limited to the liver in selected cases.
14.10
MR-guided laser induced thermotherapy of metastases
T.J. Vogl, M. Mark, Dept. ofRadiology, University ofBerlin,
Germany
Introduction: Interstitial laser-induced thermotherapy (LITT) is a
recently developed, minimally invasive technique for local tumor
destruction with solid organs. The key is the MRI method used that will
be described.
Materials and methods: 17 patients with head and neck tumors (9
recurrent squamous cell carcinomas, 7 patients with lymphnode
metastases, 2 benign pleomorphic adenomas) were treated using MR
controlled laser-induced thermotherapy. Additionally 7 patients with
primary head and neck cancer and livermetastases were treated with MR
guided LITT. After insertion of a 7 French catheter into the tumor under
CT guidance a special thermostable plastic catheter is introduced. MR
thermometry is performed via a Turbo-FLASH sequence. It is started
precontrast and with a short delay (6 seconds) postcontrast over a total
length of 180 seconds. Nonenhanced and contrast enhanced imaging
studies are performed to evaluate qualitative and quantitative parameters
including size, morphology and contrast enhancement pattem at early and
late follow-up.
Results: MR thermometry enabled on-line display of the hyperthermic
effects. We were able to induce coagulative necrosis in all patients with
head andneck cancer (volume range: 3 cc to 25 cc) and to reduce clinical
symptoms in four patients. In patients with liver metastases we observed
agood response and local tumor control.
Conclusion: The newly designed MR-guided LITT allows accurate on-
line thermometry during the interventional procedure. Dynamic
gadolinium enhanced MRI is suitable for early and late follow up studies
for lesions treated with LITT. Follow-up studies indicate that the laser
induced effects lead to reliable palliation in metastatic head and neck
cancer.
14.12
The value ofscreening for distant metastases in patients at risk prior
to head and neck cancer surgery
R. de Bree, C.R. Leemans, E.E. Deurloo, G.B. Snow, Dept. of ORL,
UTniversity ofAmsterdam, TheNetherlands
Introduction: It is important to exclude distant metastases (DM)
prior to head and neck cancer surgery in patients at high risk
because cure cannot be anticipated.
Patients and Methods: Between 1993 and 1996, 103 patients
were screened for DM. The main indications were planned surgical
therapy in patients with three or more nodal metastases (n=3D21),
low-jugular nodes (n=3D14), nodes measuring 6 cm (n=3D10),
and contralateral neck metastases n=3D31). Also total
glossectomy (n=3D13), surgery for recurrence (n=3D31) or
second primary tumour (n=3D13) indicated screening for DM.
Patients underwent bone scintigraphy (n=3D105), CT-thorax
(n=3D103) and examination ofthe liver (n=3D101; 85 ultrasounds
and 16 CT-scans).
Results: In 18 patients abnormal results were obtained. Seventeen
CT-thorax showed pulnonary/mediastinal metastases or a
bronchogenic carcinoma. Bone metastases were diagnosed in 4
patients (who also had an abnormal CT-thorax). One patient had
liver metastases. Fourteen ofthe remaining 85 developed distant
metastases during follow-up; bone (n=3D4), pulmonary (n=3D12),
liver (n=3D3), brain (n=3D2).
Conclusion: CT-scan ofthe thorax has the highest sensitivity in
screening for DM at the time of surgery in head and neck cancer
patients at risk and should probably be the only investigation since
it can easilybe extended to include the liver.